Phase 1 Metastatic Tumor Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Ovarian CancerOvarian CarcinomaAdvanced Solid Tumor+8 more
NiKang Therapeutics, Inc.150 enrolled19 locationsNCT06586957
Recruiting
Phase 1
TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors
Solid Metastatic Tumor
Neowise Biotechnology24 enrolled1 locationNCT07266298
Recruiting
Phase 1
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Ovarian CancerAdvanced Solid TumorMetastatic Tumor+2 more
Weijia Fang, MD30 enrolled1 locationNCT05518253